Pharma channel feed

Pfiz­er, Gilead and oth­ers seek clar­i­fi­ca­tions on tri­al de­signs out­lined in FDA's UC and Crohn's draft guid­ance

3 years ago

Medicare pays $700M+ an­nu­al­ly for dis­card­ed drugs. That's about to change

3 years ago

Bris­tol My­ers launch­es pro­gram to make clin­i­cal tri­als more ac­ces­si­ble for peo­ple with dis­abil­i­ties

3 years ago

Phar­ma reps re­turn to doc­tors' of­fices, but dig­i­tal chan­nels re­main im­por­tant, new da­ta show

3 years ago
Marketing

Bio­gen posts a sol­id quar­ter but chops drugs and qui­et­ly pays out $900M in le­gal set­tle­ment ahead of close­ly watched read­out

3 years ago

No­var­tis scraps key PD-1 sub­mis­sion, while tout­ing 'sig­nif­i­cant bolt-on M&A fire­pow­er'

3 years ago

J&J tones down M&A hype — down­shifts to 'neu­tral po­si­tion' while trim­ming sales guid­ance

3 years ago

FDA slaps Im­prim­is­Rx with a warn­ing let­ter over spon­sored ar­ti­cles in med­ical jour­nals

3 years ago
Marketing

WuXi Bi­o­log­ics serves up $1.4B ex­pan­sion of re­search and man­u­fac­tur­ing cen­ter in Sin­ga­pore

3 years ago
Manufacturing

Mar­ket­ingRx roundup: Pfiz­er de­buts new ‘Menopause’ pod­cast sea­son; Pfiz­er, Mod­er­na nab top spots on in­no­va­tion list

3 years ago
Marketing

Phar­mas change up lo­gos in June to sig­nal LGT­BQ+ sol­i­dar­i­ty, but ex­perts call for push be­yond ‘rain­bow wash­ing’

3 years ago
Marketing

In­cyte nabs sec­ond ap­proval with JAK in­hibitor cream for vi­tili­go

3 years ago
FDA+

Look­ing to climb out of bear mar­ket and FDA hur­dles, Sum­mit of­fers up $100M worth of stock

3 years ago
Financing

Lyn­parza fails a PhI­II test in col­orec­tal can­cer, cut­ting off big R&D av­enue for Mer­ck and As­traZeneca

3 years ago
R&D

Ei­sai shut­ters on­col­o­gy unit, cuts around 80 jobs

3 years ago

Bio­gen sees more than 330 de­par­tures from MA-based sites since last sum­mer

3 years ago

GSK nets a deal with Cana­di­an gov­ern­ment for flu vac­cine man­u­fac­tur­ing

3 years ago
Manufacturing

Khloé Kar­dashi­an strikes again with mi­graine med Nurtec mar­ket­ing in ‘all in one’ push

3 years ago
Marketing

Phar­ma R&D spend­ing in the US more than dou­bles in a decade, PhRMA sur­vey finds

3 years ago

Eu­rope buys 54,000 more dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine as cas­es in­crease

3 years ago

Am­gen ex­pands Sto­ryCorps on­col­o­gy cam­paign with celebri­ty ac­tor, preps for up­com­ing health eq­ui­ty sto­ries

3 years ago
Marketing

GSK's con­sumer health unit Ha­le­on off to a rough start

3 years ago

Sanofi waves the white flag on Reg­u­lus' mi­croR­NA pro­gram tar­get­ing rare kid­ney dis­ease

3 years ago

DNA se­quenc­ing gi­ant Il­lu­mi­na bat­tles an­titrust reg­u­la­tors and grow­ing com­pe­ti­tion

3 years ago
In Focus
First page Previous page 186187188189190191192 Next page Last page
A service from the Financial Times